Contact
Header_1077x260px_About_Profil.jpg

Glucose-Responsive Insulin

New timelines for the EU Portal and implementation of the EU Clinical Trial Regulation

Work stress is the new smoking

Even moderate overweight increases the risk for cardiovascular disease, recent study says

Clamp studies with ultra-long-acting insulins – New challenges for an old procedure

Gut Microbiota and Type 2 Diabetes

CGM in pregnant women with type 1 diabetes

Cardiovascular endpoints in trials with glucose-lowering medications

SUSTAIN 7 - Semaglutide is superior to Dulaglutide

Profil announces new live Online Seminar Session